RNS Number : 9169F
Smithson Investment Trust PLC
23 April 2025
 

 

Smithson Investment Trust plc

 

Legal Entity Identifier: 52990070BDK2OKX5TH79

 

Results of AGM - 23 April 2025

 

Smithson Investment Trust plc (the "Company") is pleased to announce that all the resolutions put forward at its Annual General Meeting held earlier today were passed. 

 

The text of all the resolutions is contained in the Notice of Annual General Meeting published on the Company's website (www.smithson.co.uk).

 

The proxy votes received were as follows:-

 

 

Resolution

 

In Favour / Discretionary

Against

Withheld

 



Votes

%

Votes

%

Votes

1.

To receive and accept the Annual Report and Accounts for the year ended 31 December 2024.

41,443,539

99.98%

8,092

0.02%

11,296

2.

To approve the Directors' Remuneration Report.

40,987,664

98.95%

436,326

1.05%

38,937

3.

To approve a final dividend of 0.58p per ordinary share in respect of the year ended 31 December 2024, to be paid on 2 May 2025.

41,126,417

99.21%

326,294

0.79%

10,216

4.

To elect Mike Balfour as a Director of the Company.

40,417,038

97.62%

983,293

2.38%

62,596

6.

To re-elect Jeremy Attard-Manche as a Director of the Company.

38,579,295

96.66%

1,333,071

3.34%

1,709,040

7.

To re-elect Denise Hadgill as a Director of the Company.

38,869,090

97.38%

1,045,102

2.62%

1,707,214

8.

To re-appoint Deloitte LLP as auditor to the Company.

41,190,787

99.11%

369,141

0.89%

61,478

9.

To authorise the Directors to fix the remuneration of the auditor until the conclusion of the next AGM.

41,087,522

99.16%

349,051

0.84%

26,354

10.

That the amendment to the Company's investment policy be approved.

41,202,659

99.07%

387,490

0.93%

31,257

11.

To authorise the Directors to allot up to 10% of the issued ordinary share capital of the Company as at 3 March 2025.

41,146,126

98.91%

451,603

1.09%

23,677

12.

In addition to 11, to authorise the Directors to allot up to 10% of the issued ordinary share capital as at 3 March 2025.

41,140,844

98.90%

455,783

1.10%

24,779

13.

To disapply the pre-emption rights in relation to the allotment of shares under resolution 11.*

40,712,908

97.87%

884,960

2.13%

23,538

14.

To disapply the pre-emption rights in relation to the allotment of shares under resolution 12. *

40,682,140

97.80%

914,665

2.20%

24,601

15.

To authorise the Company to make market purchases of ordinary shares in the Company. *

40,083,285

96.71%

1,362,436

3.29%

17,206

16.

To authorise the Directors to call general meetings (other than AGMs) on not less than 14 clear days' notice.*

41,178,737

98.98%

423,772

1.02%

18,897

17.

That the Company continues in being as an investment trust.

36,180,359

96.24%

1,413,870

3.76%

2,506,175

  

*Special resolution

 

On the 17 April 2025, the record date for voting at the meeting, the Company's issued share capital consisted of 177,107,958 ordinary shares. There were 55,052,978 ordinary shares held in treasury. The total number of ordinary shares with voting rights in the Company was 122,054,980.

 

Copies of all the resolutions passed, other than ordinary business, will be submitted to the National Storage Mechanism and will shortly be available for inspection at:- https://data.fca.org.uk/#/nsm/nationalstoragemechanism

 

 

23 April 2025

 

Enquiries

Apex Listed Companies Services (UK) Limited

Company Secretary

 

t: +44 20 3994 7161

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGUOUVRVRUSUAR